Table 3. Comparison between plasma Chromium levels in obesity, diabetes and dyslipidaemia in the study population.
| Parameters | Total (n = 331) n (%) |
Cr level (μg/l) Mean ± SEM |
p-value |
|---|---|---|---|
| WC (cm) | |||
| central obesity | 108 (33.0%) | 0.133 ± 0.01 | <0.0001 |
| Normal | 223 (67.0%) | 0.308 ± 0.02 | |
| BMI (Kg/m2) | |||
| Normal | 220 (66.5%) | 0.319 ± 0.03 | 1(reference) |
| Overweight | 61 (18.4%) | 0.217 ± 0.01 | 0.036 |
| Obese | 50 (15.1%) | 0.139 ± 0.02 | 0.003 |
| WHR | |||
| Normal | 141 (42.6%) | 0.355 ± 0.03 | <0.0001 |
| Obese | 190 (57.4%) | 0.138 ± 0.01 | |
| WHtR | |||
| Normal | 147 (44.4%) | 0.358 ± 0.02 | <0.0001 |
| Obese | 184 (56.6%) | 0.132 ± 0.01 | |
| WTR | |||
| Normal | 268 (81.8%) | 0.281 ± 0.01 | <0.0001 |
| Obese | 63 (18.2%) | 0.092 ± 0.02 | |
| FBG | |||
| Normal | 181 (54.7%) | 0.397 ± 0.02 | <0.0001 |
| Diabetic | 150 (45.3%) | 0.078 ± 0.01 | |
| TG (WHO Criteria) | |||
| Normal | 268 (81.0%) | 0.263 ± 0.01 | 0.844 |
| Dyslipidaemia | 63 (19.0%) | 0.220 ± 0.04 | |
| TG (NCEP III Criteria) | |||
| Normal | 259 (78.2%) | 0.256 ± 0.01 | 0.828 |
| Dyslipidaemia | 72 (21.8%) | 0.230 ± 0.04 |
Comparison of plasma Cr level in obesity, diabetes and dyslipidaemia in the study population
n (%): frequency (percentage). One-sample t-test was used in comparison between means Cr levels.p < 0.05 was considered statistically significant
BG: Fasting blood Glucose, WHR: Waist to hip ratio; WTR: Waist to thigh ratio; WHtR: Waist to height ratio; BMI: Body mass index; WC: Waist circumference; HC: Hip circumference TG; triglycerides